Applications of BMP Signaling Pathway Regulators in Stem Cell Differentiation, Organoid Culture and Developmental Research

The BMP signaling pathway is an important signaling network that regulates embryonic development, tissue homeostasis, cell fate determination and regenerative repair. Through combined regulation using exogenous BMP ligands, receptor inhibitors, antagonistic proteins and pathway-coordinating factors, signaling environments corresponding to different developmental stages can be reconstructed in vitro for directed stem cell differentiation, organoid formation and developmental mechanism studies.

 

Keywords: BMP signaling pathway; stem cell differentiation; organoid culture; developmental biology; BMP inhibitor; SMAD signaling

 

1 Regulatory Basis of the BMP Signaling Pathway

1.1 Pathway Components

(1) BMP ligands

BMPs belong to the TGF-β superfamily. Common members include BMP2, BMP4, BMP7 and BMP9. Different BMP ligands have distinct roles in germ layer establishment, neural induction, osteochondral differentiation, angiogenesis and organ development. In vitro culture systems often use recombinant BMP proteins to simulate exogenous signaling input during developmental stages.

(2) BMP receptors

BMP signaling is mainly transmitted through type I and type II serine/threonine kinase receptors. After ligand binding, the type II receptor phosphorylates and activates the type I receptor, thereby initiating downstream SMAD-dependent signaling. Different cells express different receptor types, so the same BMP ligand may produce different effects in different cell types.

(3) SMAD transcriptional regulation

The canonical BMP pathway transmits signals through phosphorylation of SMAD1/5/8. Phosphorylated SMAD1/5/8 forms a complex with SMAD4 and enters the nucleus to regulate the expression of ID genes, developmental transcription factors, cell-cycle factors and lineage markers. p-SMAD1/5/8 is usually an important indicator for determining whether the BMP pathway is activated.

 

1.2 Regulatory Levels of the Pathway

(1) Ligand-level regulation

Exogenous addition of BMP2, BMP4 or BMP7 can enhance pathway activity. Antagonistic proteins such as Noggin, Gremlin and Chordin can bind BMP ligands and block their binding to receptors. This regulatory level is suitable for simulating BMP gradient changes during development.

(2) Receptor-level regulation

Small molecules such as LDN-193189, DMH-1, DMH2 and K 02288 can inhibit BMP type I receptor kinase activity and reduce SMAD1/5/8 phosphorylation. Receptor inhibitors are commonly used for neural induction, organoid patterning and pathway-dependence validation.

(3) Pathway interaction regulation

BMP signaling rarely determines cell fate alone, and usually acts together with pathways such as Wnt, FGF, TGF-β/Activin/Nodal, RA, Notch and Hedgehog. The timing, dose and combination of different pathways are central to the design of stem cell differentiation and organoid culture systems.

 

2 Main Types of BMP Regulators

2.1 Activating Regulators

(1) Recombinant BMP proteins

BMP2, BMP4 and BMP7 are commonly used to externally activate the BMP pathway. BMP4 is frequently used in mesoderm induction, trophoblast-like differentiation and embryoid structure models. BMP2 is commonly used for osteogenic and chondrogenic induction. BMP7 is often used in kidney, neuroprotection and epithelial-related models.

(2) Small-molecule agonists

Small molecules such as BMP agonists and BMP4 agonists can be used to enhance BMP-related signaling output. Compared with recombinant proteins, small molecules are more convenient for dose-gradient setup and high-throughput screening, but their pathway specificity should be confirmed using indicators such as p-SMAD1/5/8 and ID1.

(3) Synergistic induction factors

BMP signaling often needs to be combined with Wnt activators, FGF, RA or osteogenic induction components. For example, BMP and Wnt can synergistically promote mesodermal and cardiovascular lineage induction, while BMP combined with β-glycerophosphate, ascorbic acid and dexamethasone can promote osteogenic differentiation.

 

2.2 Inhibitory Regulators

(1) BMP receptor inhibitors

LDN-193189, DMH-1, DMH2 and K 02288 can inhibit BMP type I receptor-related signaling and reduce SMAD1/5/8 phosphorylation. These inhibitors are commonly used for neural ectoderm induction, intestinal organoid patterning and BMP-dependence validation.

(2) BMP antagonistic proteins

Noggin is a commonly used BMP antagonist in organoid culture, especially in intestinal, gastric, pancreatic and some epithelial organoid systems, where it helps maintain the stem cell niche. Gremlin and Chordin-related factors can also serve as important components of the BMP ligand antagonism axis and are used to analyze developmental axial patterning and signaling gradients.

(3) Gene intervention tools

siRNAs or knockout cell lysates targeting BMP ligands, BMP receptors, SMAD members and downstream genes such as ID1 can be used to validate pathway causality. These tools are suitable for answering whether a specific BMP node is necessary, rather than merely observing correlation changes after exogenous factor treatment.

 

3 Applications in Stem Cell Differentiation

3.1 Germ Layer Fate Regulation

(1) Ectoderm induction

BMP inhibition is a key strategy in neural ectoderm induction. During the differentiation of human pluripotent stem cells toward the neural lineage, inhibition of BMP and TGF-β/Activin/Nodal signaling is often used to reduce non-neural lineage interference and improve the efficiency of neural epithelial-like cell generation.

(2) Mesoderm induction

BMP4, together with Wnt, Activin/Nodal and other signals, can promote mesoderm formation. During induction, BMP signal intensity and exposure duration determine whether cells shift toward cardiovascular, hematopoietic, osteochondral or muscle lineages. Excessively strong or prolonged BMP signaling may result in mixed lineage outcomes.

(3) Endoderm and its derivative lineages

The role of BMP in endoderm differentiation is stage-dependent. In early endoderm induction, BMP signaling can cooperate with Activin/Nodal. During subsequent patterning toward foregut, liver, pancreas or intestinal lineages, BMP levels need to be precisely controlled to avoid lineage deviation.

 

3.2 Osteogenic, Chondrogenic and Mesenchymal Differentiation

(1) Osteogenic differentiation

BMP2 and BMP4 can promote the expression of osteogenic markers such as RUNX2, ALP, COL1A1 and OCN. In in vitro osteogenic systems, BMPs are usually combined with ascorbic acid, β-glycerophosphate and dexamethasone to enhance matrix maturation and mineralization.

(2) Chondrogenic differentiation

BMP2, BMP4 and BMP7 can promote cartilage matrix formation and work together with TGF-β signaling to affect SOX9, COL2A1 and ACAN expression. Excessive BMP in chondrogenic induction may promote hypertrophy, so differentiation quality should be assessed using indicators such as COL10A1 and MMP13.

(3) Mesenchymal lineage balance

Mesenchymal stem cells are sensitive to BMP signaling. BMP activation can promote osteogenic or chondrogenic tendency, but may also affect adipogenic differentiation and fibrosis-related phenotypes. Interpretation should be based on induction factor combinations and time windows.

 

3.3 Cardiovascular and Hematopoietic Differentiation

(1) Cardiomyocyte induction

Stage-specific coordination between BMP and Wnt signaling can promote mesoderm and early cardiac progenitor formation. In cardiomyocyte differentiation, Wnt/BMP-related signaling is often activated first to establish mesoderm, followed by inhibition of specific pathways at later stages to promote cardiomyocyte maturation.

(2) Vascular and endothelial differentiation

BMP4, BMP9 and BMP10 can all participate in vascular endothelial regulation. When combined with factors such as VEGF and FGF, they can improve endothelial marker expression and vascular-like structure formation.

(3) Hematopoietic models

BMP signaling participates in primitive hematopoiesis and angiogenesis-related developmental processes. In in vitro models, BMP signal intensity, Wnt activity and cell aggregation state can affect hematopoietic lineage induction efficiency.

 

4 Applications in Organoid Culture

4.1 Intestinal Organoids

(1) Stem cell maintenance

In the intestinal crypt microenvironment, BMP signaling is usually antagonized to maintain the stem cell zone. Noggin is often used together with EGF and R-spondin in intestinal organoid culture to inhibit BMP signaling and support LGR5-positive stem cell maintenance.

(2) Differentiation regulation

When BMP antagonism is reduced or BMP signaling is enhanced, intestinal organoids may show increased differentiation, reduced proliferative zones and changes in crypt-like structures. BMP intensity can be used to regulate the balance between stem cell maintenance and epithelial differentiation.

(3) Disease models

BMP pathway abnormalities are associated with intestinal epithelial renewal, inflammatory repair and tumorigenesis. By regulating BMP or Noggin levels, changes in the intestinal niche can be simulated to analyze epithelial regeneration and pathological differentiation processes.

 

4.2 Gastric, Pancreatic and Liver Organoids

(1) Gastric organoids

BMP signaling participates in gastric epithelial regionalization and glandular structure formation. In vitro, BMP inhibition is often used to maintain a stem cell-like state, while BMP activation can promote differentiation and tissue structure maturation.

(2) Pancreatic organoids

Pancreatic lineage formation has stage-specific requirements for BMP signaling. Excessively strong BMP signaling at early stages may affect foregut and pancreatic fate selection, while moderate regulation at later stages can influence the proportions of duct-like, acinar-like or endocrine-like cells.

(3) Liver organoids

BMP works together with FGF, HGF, OSM and other signals to participate in hepatocyte-like cell induction and maturation. Early BMP signaling helps establish hepatic progenitor fate, but subsequent maturation stages require coordinated optimization with other factors.

 

4.3 Neural and Brain Organoids

(1) Neural induction

In brain organoid and neural organoid construction, BMP inhibition is commonly used to improve neural ectoderm induction efficiency. If BMP signaling is not sufficiently inhibited, cells may deviate toward non-neural ectodermal, epidermal-like or mesenchymal-like directions.

(2) Regional patterning

In specific brain region organoids, BMP signaling can work together with Wnt, SHH, FGF and RA to regulate dorsal-ventral axes, anterior-posterior axes and cortical-like structure formation. BMP regulation at different time windows affects neural progenitor proportions and neuronal differentiation directions.

(3) Neural crest and boundary structures

Moderate BMP signaling can participate in neural crest cell induction. If the study focuses on neural crest, ectodermal boundaries or sensory nerve-related models, BMP signaling should not simply be inhibited, but needs to be jointly regulated with Wnt and FGF.

 

5 Applications in Developmental Research

5.1 Embryonic Pattern Formation

(1) Axis establishment

BMP signaling plays a key role in embryonic dorsal-ventral axis formation, ectodermal patterning and gastrulation movements. By changing BMP ligand or antagonist levels, different signaling gradients can be simulated to analyze tissue regionalization and fate allocation mechanisms.

(2) Germ layer boundary formation

BMP signaling works together with Nodal, Wnt, FGF and other pathways to determine germ layer boundaries. In vitro embryoid structures, embryo-like models and micropatterned culture systems often use BMP4 to induce spatialized cell fate distribution.

(3) Morphogenesis

BMP not only regulates gene expression, but also affects cell migration, epithelial-mesenchymal transition, cell polarity and tissue folding. Developmental models should therefore evaluate both molecular markers and morphological changes.

 

5.2 Organogenesis Models

(1) Skeletal and cartilage development

BMP signaling promotes osteochondral progenitor formation and matrix deposition, making it an important regulatory axis for studying skeletal development, bone regeneration and cartilage formation. Excessive BMP activity may also induce ectopic ossification or cartilage hypertrophy.

(2) Kidney and urinary system development

BMP7 plays an important role in kidney development and renal progenitor cell maintenance. In kidney organoids or kidney development models, BMP signaling needs to be regulated together with Wnt, FGF and RA signaling.

(3) Vascular and cardiac development

BMP9, BMP10 and BMPR2-related signaling are closely associated with vascular endothelium, cardiovascular development and vascular homeostasis. Combined regulation with VEGF, FGF and Wnt can be used to construct vascularized organoids or cardiovascular development models.

 

5.3 Disease and Regeneration Research

(1) Fibrosis and abnormal differentiation

Abnormal BMP signaling may participate in fibrosis, ectopic ossification and tissue remodeling. By regulating BMP activity or the Gremlin-BMP antagonistic axis, researchers can analyze fibroblast activation, mesenchymal transition and pathological matrix deposition.

(2) Tissue injury repair

BMP participates in fracture repair, cartilage injury, skin regeneration and epithelial repair. In different tissues, BMP signaling may have dual roles in promoting repair and inducing abnormal remodeling.

(3) Genetic developmental disease models

Mutations in BMP pathway-related genes can affect skeletal, cardiovascular, neural and organ formation. Stem cell and organoid models can be used to reconstruct disease-related developmental abnormalities in vitro.

 

6 Experimental Design and Evaluation Indicators

6.1 Design of Regulatory Strategies

(1) Dose gradient

BMP signaling shows clear dose dependence. Low doses may be insufficient to induce lineage conversion, while high doses may lead to non-target lineages or cellular stress. Experiments should include concentration gradients of ligands, agonists or inhibitors.

(2) Time window

BMP signaling is stage-dependent. Early activation and late activation may produce completely different cell fate outcomes. In stem cell differentiation and organoid culture, the timing of regulation is often more important than a single concentration.

(3) Combinatorial regulation

BMP should be designed together with Wnt, TGF-β/Activin/Nodal, FGF, RA and matrix conditions. Changing BMP alone may make complex phenotypes difficult to interpret, so pathway crosstalk should be analyzed.

 

6.2 Detection of Pathway Activity

(1) p-SMAD1/5/8

p-SMAD1/5/8 is an important indicator for evaluating activation of the canonical BMP pathway. Its expression and nuclear localization can be detected by Western blot, immunofluorescence, flow cytometry or immunohistochemistry.

(2) Downstream target genes

ID1, ID2, ID3, MSX1 and MSX2 are commonly used as downstream response genes of BMP signaling. Downstream gene profiles may differ among cell types, so indicators should be selected based on the research model.

(3) Detection of ligands and antagonists

Factors such as BMP2, BMP4, BMP7, BMP9, Noggin and Gremlin can be evaluated by ELISA, immunoassays or transcript-level analysis to determine signaling input and the antagonistic environment in the culture system.

 

6.3 Functional and Structural Evaluation

(1) Evaluation of 2D differentiation

In 2D differentiation systems, cell fate conversion can be evaluated by qPCR, Western blot, immunofluorescence, flow cytometry and functional staining. Osteogenic differentiation can be assessed by ALP activity and mineralized nodules, while neural differentiation can be assessed by neural epithelial and neuronal markers.

(2) Evaluation of organoid structure

Organoid research should assess formation efficiency, size, branching structure, polarity, cellular composition and regionalization markers. Detection of a single gene expression marker is insufficient to judge organoid quality.

(3) Evaluation of developmental models

Developmental research should combine spatial markers, tissue morphology, cell migration and temporal dynamics. For embryoid structures or patterning models, signaling gradients and spatial distribution are more important than average expression levels.

 

7 Selection of BMP Signaling Pathway Regulators

7.1 BMP Signaling Pathway Regulators and Validation Tools

 

Product Module	Cat. No.	Product Name	Grade/Purity	Functional Positioning	Recommended Application Scenario
BMP pathway agonist	B1448944	BMP agonist 1		Activates BMP-related signaling	BMP pathway activation, stem cell differentiation induction, pathway functional enhancement experiments
BMP pathway agonist	B1454659	BMP agonist 2	≥99%	Activates BMP-related signaling	BMP pathway activation, developmental signal simulation, osteogenic/mesoderm induction research
BMP4 agonist	S286588	SB 4	≥98%	Agonist of BMP4-related signaling	BMP4-dependent differentiation, developmental patterning and pathway activation validation
BMP receptor inhibitor	L127229	LDN-193189	≥98%	Inhibits BMP type I receptor	Neural induction, dual SMAD inhibition, organoid patterning, BMP-dependence validation
BMP receptor inhibitor	D275100	DMH-1	≥98%	Inhibits BMP type I receptor	Neural differentiation, vascular models, BMP-SMAD signal blockade experiments
BMP receptor inhibitor	D287316	DMH2	≥98%(HPLC)	Inhibits type I BMP receptor	Stem cell lineage regulation, BMP signaling inhibition in organoid culture
BMP receptor inhibitor	K287246	K 02288	≥98%	Inhibits type I BMP receptor	BMP pathway inhibition, p-SMAD1/5/8 downregulation validation
BMPR2 inhibitor	B1454692	BMPR2-IN-1 TFA	≥99%	Regulates BMPR2-related signaling	BMPR2 functional research, vascular/development-related BMP signaling analysis
BMP1/PCP inhibitor	U125948	UK 383367	≥98%	Inhibits BMP1/PCP-related protease activity	Matrix remodeling, osteochondral development and tissue morphogenesis-related research
BMP-derived peptide	B1454675	BMP2-derived peptide	≥98%	BMP2-related functional peptide	BMP2 structure-function research, ligand active fragment and material modification experiments
BMP ligand protein	rp168355-GMP	Recombinant Human BMP-2 GMP Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,sterile,≥95%(SDS-PAGE)	Activates BMP2 signaling	Osteogenic differentiation, bone regeneration, GMP-grade cell culture systems
BMP ligand protein	rp164886-GMP	Recombinant Human BMP-4 GMP Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,His Tag,≥95%(SDS-PAGE),See COA	Activates BMP4 signaling	Mesoderm induction in pluripotent stem cells, embryoid models, GMP-grade culture systems
BMP ligand protein	rp330090	Recombinant Human BMP2 Protein	≥90%(SDS-PAGE)	Activates BMP2 signaling	Osteogenic, chondrogenic and mesenchymal lineage induction
BMP ligand protein	rp329653	Recombinant Human BMP4 Protein	≥95%(SDS-PAGE)	Activates BMP4 signaling	Mesoderm induction, embryo-like models, developmental patterning experiments
BMP ligand protein	rp329804	Recombinant Human BMP7 Protein	≥90%(SDS-PAGE)	Activates BMP7 signaling	Kidney development, epithelial differentiation, tissue protection and repair research
BMP ligand protein	rp330131	Recombinant Human BMP9 Protein	≥90%(SDS-PAGE)	Activates BMP9/GDF2-related signaling	Vascular endothelial differentiation, hepatocyte-like cell models, angiogenesis research
BMP ligand protein	rp330253	Recombinant Human BMP9 Protein	≥90%(SDS-PAGE)	Activates BMP9/GDF2-related signaling	Endothelial cell function, vascular development and BMP9 pathway research
BMP ligand protein	rp143300	Recombinant Human BMP3 Protein	ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥95%(SDS-PAGE&HPLC)	BMP3-related developmental regulation	Bone development, bone metabolism and BMP family functional comparison
BMP ligand protein	rp330091	Recombinant Rat BMP2 Protein	≥90%(SDS-PAGE)	Activates rat BMP2-related signaling	Differentiation of rat-derived cells, in vitro validation related to animal models
BMP ligand protein	rp173575	BMP-10	Moligand™	BMP10-related signaling	Cardiovascular development, endothelial function and BMP family comparison research
BMP ligand protein	rp173576	BMP-15	Moligand™	BMP15-related signaling	Reproductive development, ovarian/follicle-related models
BMP ligand protein	rp173581	BMP-6	Moligand™	BMP6-related signaling	Bone development, iron metabolism, stem cell differentiation research
BMP ligand protein	rp173582	BMP-7	Moligand™	BMP7-related signaling	Kidney, epithelial and tissue repair-related research
BMP ligand protein	rp173585	BMP-9	Moligand™	BMP9-related signaling	Angiogenesis, endothelial function, hepatocyte-like differentiation research
BMP receptor protein	rp143319	Recombinant Human BMPR-IA/ALK-3 Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,Azide Free,His Tag,≥95%(SDS-PAGE),See COA	BMP type I receptor	Receptor binding, ligand-receptor interaction and BMP pathway mechanism research
BMP receptor protein	rp143325	Recombinant Human BMPR-IB/ALK-6 Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,His Tag,≥90%(SDS-PAGE)	BMP type I receptor	Osteochondral differentiation, receptor function and ligand screening research
BMP receptor protein	rp143327	Recombinant Human BMPR2 protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,Azide Free,His Tag,≥95%(SDS-PAGE)	BMP type II receptor	BMPR2-mediated signaling, vascular development and receptor function validation
BMP receptor protein	rp329445	Recombinant Human BMPR2 Protein	≥90%(SDS-PAGE)	BMP type II receptor	BMPR2 pathway research, ligand binding and mechanistic analysis
BMP antagonistic protein	rp167884-GMP	Recombinant Human Noggin GMP Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,High Performance,Fc Tag,PBS Only,≥90%(SDS-PAGE&SEC-HPLC)	Antagonizes BMP ligands	Intestinal, gastric and pancreatic organoid culture; GMP-grade niche construction
BMP antagonistic protein	rp149360	Recombinant Human Noggin Protein	Animal Free,Carrier Free,Bioactive,ActiBioPure™,Azide Free,His Tag,≥95%(SDS-PAGE)	Inhibits BMP signaling	Organoid stem cell maintenance, neural induction, BMP-inhibited culture systems
BMP antagonistic protein	rp156341	Recombinant Human Noggin Protein	Animal Free,Carrier Free,His Tag,PBS Only,≥90%(SDS-PAGE),See COA	Inhibits BMP signaling	Organoid culture, epithelial stem cell maintenance and BMP antagonism experiments
BMP antagonistic protein	rp146650	Recombinant Human Gremlin 1 Protein	Carrier Free,Bioactive,ActiBioPure™,Azide Free,His Tag,≥98%(SDS-PAGE)	Antagonizes BMP2/4/7 and related signals	Developmental gradients, fibrosis, tissue remodeling and BMP antagonism mechanism research
BMP antagonistic protein	rp174168	gremlin 1	Moligand™	BMP antagonism-related factor	BMP signaling inhibition, developmental regulation and tissue remodeling research
Gremlin antibody/blocking tool	Ab175549	Ginisortamab (anti-Gremlin)	Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA	Targets Gremlin	Gremlin-BMP antagonistic axis, fibrosis and disease model research
BMP detection antibody	Ab091424	Recombinant BMP4 Antibody	Recombinant, ExactAb™, Validated, High Performance, See COA	Detects BMP4	BMP4 expression detection, developmental models and organoid immunoanalysis
BMP detection antibody	Ab091437	Recombinant BMP7 Antibody	Recombinant, ExactAb™, Validated, See COA	Detects BMP7	BMP7 expression, kidney/epithelial models and tissue repair research
BMP detection antibody	Ab091432	BMP6 Antibody	Carrier Free, ExactAb™, Validated, 1.0 mg/mL	Detects BMP6	Bone development, iron metabolism and BMP6 pathway analysis
BMP detection antibody	Ab091408	BMP10 Antibody	ExactAb™, Validated, 1.0 mg/mL	Detects BMP10	Cardiovascular development, endothelial function and BMP10 expression analysis
BMP detection antibody	Ab091421	BMP3 Antibody	ExactAb™, Validated, 1.0 mg/mL	Detects BMP3	BMP3 expression, bone metabolism and developmental research
BMP detection antibody	Ab091407	BMP1/PCP Mouse mAb	See COA	Detects BMP1/PCP	Matrix processing, osteochondral development and tissue remodeling research
SMAD detection antibody	Ab128163	Recombinant Smad1 Antibody	ExactAb™, Validated, Recombinant, 0.8 mg/mL	Detects SMAD1	Detection of total SMAD levels in the canonical BMP pathway
SMAD detection antibody	Ab326508	Recombinant SMAD Family Member 1 Antibody	KD Validation	Detects SMAD1	BMP-SMAD pathway validation, knockdown model analysis
SMAD detection antibody	Ab327093	Recombinant SMAD5 Antibody	KD Validation	Detects SMAD5	Downstream validation of p-SMAD1/5/8-related pathways
SMAD detection antibody	Ab128237	SMAD5 Mouse mAb	ExactAb™, Validated, 1.6 mg/mL	Detects SMAD5	BMP signal output, organoid and differentiation model detection
SMAD detection antibody	Ab128243	SMAD6 Antibody	Validated, ExactAb™, 1.0 mg/mL	Detects SMAD6	BMP negative feedback regulation, inhibitory SMAD analysis
SMAD detection antibody	Ab128246	SMAD9 Antibody	Carrier Free, ExactAb™, Validated, High Performance, See COA	Detects SMAD9	Canonical BMP pathway, SMAD8/9-related signaling research
ID1 detection antibody	Ab109300	Recombinant Id1 Antibody	ExactAb™, Validated, Recombinant, 1.2 mg/mL	Detects ID1	Detection of BMP downstream response gene, pathway output validation
SMAD negative regulation antibody	Ab113970	MADH7/SMAD7 Antibody	Validated, 1.0 mg/mL	Detects SMAD7	BMP/TGF-β negative feedback, pathway inhibition mechanism research
BMP gene intervention	B1480088	BMP2 Human Pre-designed siRNA Set A		Downregulates BMP2	BMP2 loss of function, osteogenic differentiation and pathway-dependence validation
BMP gene intervention	B1465701	BMP4 Human Pre-designed siRNA Set A		Downregulates BMP4	Mesoderm induction, embryo-like models and BMP4 function validation
BMP gene intervention	B1465916	BMP7 Human Pre-designed siRNA Set A		Downregulates BMP7	BMP7 research related to kidney, epithelium and tissue repair
BMP gene intervention	B1465615	BMP6 Human Pre-designed siRNA Set A		Downregulates BMP6	BMP6 loss of function, bone development and iron metabolism-related research
BMP gene intervention	B1472801	BMP10 Human Pre-designed siRNA Set A		Downregulates BMP10	Endothelial, cardiovascular development and BMP10 functional research
BMP gene intervention	B1471888	BMP15 Human Pre-designed siRNA Set A		Downregulates BMP15	Reproductive development and BMP15-related mechanism research
BMP receptor gene intervention	B1475204	BMPR1A Human Pre-designed siRNA Set A		Downregulates BMPR1A/ALK3	BMP receptor-dependence validation, stem cell differentiation mechanism analysis
BMP receptor gene intervention	B1483078	BMPR1B Human Pre-designed siRNA Set A		Downregulates BMPR1B/ALK6	Osteochondral differentiation, receptor subtype functional comparison
BMP receptor gene intervention	B1466381	BMPR2 Human Pre-designed siRNA Set A		Downregulates BMPR2	BMPR2-mediated signaling, vascular development and disease model research
BMP regulator intervention	B1460957	BMPER Human Pre-designed siRNA Set A		Downregulates BMPER	BMP regulatory factors, vascular development and endothelial signaling research
SMAD gene intervention	S1474012	SMAD1 Human Pre-designed siRNA Set A		Downregulates SMAD1	Loss-of-function validation of the canonical BMP pathway
SMAD gene intervention	S1470180	SMAD5 Human Pre-designed siRNA Set A		Downregulates SMAD5	SMAD1/5/8 signal output analysis
SMAD gene intervention	S1488082	SMAD9 Human Pre-designed siRNA Set A		Downregulates SMAD9	Canonical BMP pathway, SMAD8/9-related mechanism research
SMAD negative regulation intervention	S1471683	SMAD6 Human Pre-designed siRNA Set	BioReagent,for DNA and RNA applications,sterile,DNase, RNase free	Downregulates SMAD6	BMP negative feedback regulation and inhibitory SMAD functional research
SMAD negative regulation intervention	S1476644	SMAD7 Human Pre-designed siRNA Set	BioReagent,sterile,for DNA and RNA applications,DNase, RNase free	Downregulates SMAD7	BMP/TGF-β crosstalk regulation and negative feedback research
BMP downstream gene intervention	I1472685	ID1 Human Pre-designed siRNA Set A		Downregulates ID1	BMP downstream response, cell fate and differentiation output validation
BMP ELISA detection	EJ1515126	Human Bone Morphogenetic Protein 2 (BMP2) ELISA Kit	BioReagent	Quantitatively detects BMP2	Stem cell differentiation supernatants, tissue samples and secretion level analysis
BMP ELISA detection	EJ1515128	Human Bone Morphogenetic Protein 4 (BMP4) ELISA Kit	BioReagent	Quantitatively detects BMP4	Embryoid models, organoid culture medium and BMP4 expression analysis
BMP ELISA detection	EJ1515124	Human Bone Morphogenetic Protein 7 (BMP7) ELISA Kit	BioReagent	Quantitatively detects BMP7	Kidney models, epithelial differentiation and tissue repair research
BMP ELISA detection	EJ1514295	Human Growth Differentiation Factor 2 (GDF-2/BMP-9) ELISA Kit	BioReagent	Quantitatively detects BMP9/GDF2	Endothelial, angiogenesis and hepatocyte-like differentiation models
BMP ELISA detection	EJ1515123	Human Bone Morphogenetic Protein 6 (BMP6) ELISA Kit	BioReagent	Quantitatively detects BMP6	Bone development, iron metabolism and BMP6 secretion level analysis
BMP ELISA detection	EJ1515125	Human Bone Morphogenetic Protein 10 (BMP10) ELISA Kit	BioReagent	Quantitatively detects BMP10	Cardiovascular development and endothelial cell function research
BMP ELISA detection	EJ1515122	Human Bone Morphogenetic Protein 15 (BMP15) ELISA Kit	BioReagent	Quantitatively detects BMP15	Reproductive development and follicle-related models
Noggin detection	EJ1512528	Mouse Noggin (NOG) ELISA Kit	BioReagent	Quantitatively detects Noggin	Mouse organoids, developmental models and BMP antagonistic environment analysis
Gremlin detection	EJ1513519	Human Gremlin 1 (GREM1) ELISA Kit	BioReagent	Quantitatively detects GREM1	Gremlin-BMP antagonistic axis, fibrosis and tissue remodeling research
Gremlin detection	EJ1513520	Human Gremlin 2 (GREM2) ELISA Kit	BioReagent	Quantitatively detects GREM2	BMP antagonist expression, developmental and disease models
Gremlin detection	EJ1512511	Mouse Gremlin 1 (GREM1) ELISA Kit	BioReagent	Quantitatively detects mouse GREM1	Mouse developmental models, tissue repair and fibrosis research
Chordin-related detection	EJ1513541	Human Kielin/chordin-like Protein(KCP) ELISA Kit	BioReagent	Detects KCP	BMP regulatory factors, developmental axial patterning and pathway regulation research
SMAD ELISA detection	EJ1513638	Human SMAD Family Member 5(Smad5) ELISA Kit	BioReagent	Quantitatively detects SMAD5	Canonical BMP pathway output, cell differentiation model analysis
SMAD ELISA detection	H1510082	Human SMAD3 ELISA Kit	BioReagent	Quantitatively detects SMAD3	BMP/TGF-β crosstalk pathway and SMAD signaling research
SMAD ELISA detection	EJ1513637	Human Mothers Against Decapentaplegic Homolog 4 (Smad4) ELISA Kit	BioReagent	Quantitatively detects SMAD4	SMAD complex formation and common pathway node analysis
SMAD ELISA detection	EJ1513639	Human Mothers Against Decapentaplegic Homolog 7 (Smad7) ELISA Kit	BioReagent	Quantitatively detects SMAD7	Negative feedback regulation, BMP/TGF-β inhibition mechanism research

 

The key to BMP signaling pathway regulation lies in dose, time window and pathway combination. In stem cell differentiation, activation or inhibition strategies should be determined according to the target lineage. In organoid culture, niche signals should be integrated to maintain cellular composition and structural maturation. In developmental research, signaling gradients, spatial distribution and dynamic changes should be emphasized. Rational use of BMP ligands, antagonistic proteins, receptor inhibitors and pathway validation tools can improve the ability of in vitro models to simulate real developmental processes.

 

For more related articles, please see below:

[1] BMP Signaling Pathway: Molecular Components, Signal Transduction Mechanisms, and Biological Functions